<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01254682</url>
  </required_header>
  <id_info>
    <org_study_id>OSTWA-07-01</org_study_id>
    <nct_id>NCT01254682</nct_id>
  </id_info>
  <brief_title>Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist</brief_title>
  <official_title>Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TRB Chemedica AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TRB Chemedica AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the efficacy and safety of Ostenil
      application (1% hyaluronan) after arthroscopy of the wrist.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment 3 months after arthroscopic surgery.</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>Mayo wrist score evaluation consisting of 4 sections:
Maximal grip strength on injured side (compared to maximal strength of contralateral side, measured by 4-point scale, ranking from '0' for minimal to '30' for maximal strength)
Range of motion (measured by 4-point scale, ranking from '0' for minimal to '20' for maximal mobility)
Pain (measured by 4-point scale, ranking from '0' for maximal to '20' for minimal pain)
Function in daily activities (measured by 4-point scale, ranking from '0' for minimal to '30' for maximal function)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment.</measure>
    <time_frame>Measured during the 6-month duration of participation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disabilities of the arm, shoulder, and hand (DASH) outcome measure</measure>
    <time_frame>Measured during the 6-month duration of participation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>Measured during the 6-month duration of participation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale of pain (VAS; 100 mm)</measure>
    <time_frame>Measured during the 6-month duration of participation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression (CGI)</measure>
    <time_frame>Measured during the 6-month duration of participation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inter-group comparison of Mayo wrist subscores in subjects with or without post-arthroscopic hyaluronan treatment.</measure>
    <time_frame>Measured during the 6-month duration of participation</time_frame>
    <description>Maximal grip strength on injured side (compared to contralateral side)
Range of motion
Pain
Function in daily activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with Adverse Events as a measure of safety and tolerability</measure>
    <time_frame>Measured during the 6-month duration of participation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Arthroscopic Surgery</condition>
  <arm_group>
    <arm_group_label>Hyaluronic acid sodium salt (1%, 20mg/2ml)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard arthroscopic procedure</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ostenil</intervention_name>
    <description>Standard arthroscopy (including intra-articular injection of 5 ml scandicain (0,5%), or 5 ml bupivacain plus 5 ml suprarenin in case of post-arthroscopic treatment). Add-on treatment with Ostenil after standard arthroscopic procedure. Application twice: first injection directly after arthroscopic procedure and second injection 3 weeks post arthroscopic.</description>
    <arm_group_label>Hyaluronic acid sodium salt (1%, 20mg/2ml)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard arthroscopic procedure</intervention_name>
    <description>Standard arthroscopy (including intra-articular injection of 5 ml scandicain (0,5%), or 5 ml bupivacain plus 5 ml suprarenin in case of post-arthroscopic treatment) without add-on treatment.</description>
    <arm_group_label>Standard arthroscopic procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients between 18 and 80 years of age

          -  Minimum pain score of 2 according to modified Mayo Wrist Score

          -  Patients in good general health/nutritional condition

          -  Signed written informed consent

        Exclusion Criteria:

          -  Alcohol / drug abuse, drug addiction or neurotic personality disorder; patients with
             mental illness or suicidal tendency

          -  Severe intercurrent illness (like uncontrolled diabetes mellitus or thyroid disease,
             carcinoma,...)

          -  Fertile women without medically secured contraception(hysterectomy, sterilization,
             contraceptives,...)

          -  Subjects having a high probability of non compliance to the study procedures according
             to investigator's judgement (like illiteracy, insufficient German linguistic
             knowledge)

          -  Contraindication for the use of one of the investigational products or for the
             scheduled anesthesia

          -  Concomitant or previous participation in a clinical trial within the last 3 months

          -  Intraarticular treatment with a sodium hyaluronate-based product within the last 6
             months

          -  Intraarticular treatment by the use of corticoid containing substance within the last
             3 months

          -  Concomitant illness or injury influencing study evaluation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Schütz, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopädische Gemeinschaftspraxis, Straubing (Germany)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopädische Gemeinschaftspraxis</name>
      <address>
        <city>Straubing</city>
        <state>Bavaria</state>
        <zip>94315</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2010</study_first_submitted>
  <study_first_submitted_qc>December 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2010</study_first_posted>
  <last_update_submitted>September 27, 2011</last_update_submitted>
  <last_update_submitted_qc>September 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wrist</keyword>
  <keyword>joint</keyword>
  <keyword>arthroscopy</keyword>
  <keyword>hyaluronan</keyword>
  <keyword>hyaluronic acid</keyword>
  <keyword>Necessity of Arthroscopic surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

